SIG Group (SIGN) Q3 2025 TU earnings summary

Executive summary

• Q3 2025 revenue declined due to deteriorating consumer sentiment and customer destocking, with significant non-recurring pre-tax charges of €320 million, mainly non-cash, and up to €40 million more expected in Q4, primarily from asset impairments and strategic restructuring.

• Adjusted EBITDA margin for Q3 was 16% (24% excluding non-recurring charges), and net income for Q3 was a loss of €221.8 million.

• Innovation highlights included the commercial launch of a next-generation aseptic spouted pouch system and a successful recycling trial for 85% paper-content cartons.

• Despite market challenges, 60–70 filler placements are expected in 2025, but this will not offset lower capacity utilization.

Financial highlights

• Q3 2025 revenue was €769 million, down 6.7% reported and 3.9% at constant currency year-over-year; nine-month revenue was €2,348 million, down 2.1% reported.

• Adjusted EBITDA for Q3 was €123 million (16% margin); excluding non-recurring charges, €184 million (24% margin).

• Adjusted net income for Q3 was €17 million, or €61 million excluding non-recurring charges; net income for Q3 was a loss of €221.8 million.

• Free cash flow for Q3 was €55 million, down from €78 million in Q3 2024; nine-month free cash flow was negative €84 million.

• Net leverage increased to 3.3x as of September 30, 2025, within covenant limits.

Outlook and guidance

• 2025 full-year guidance confirmed: flat to slightly negative revenue growth at constant currency and constant resin.

• Adjusted EBITDA margin expected at ~21% including non-recurring charges, 24–24.5% excluding them.

• Cash dividend for 2025 proposed to be paused to focus on capital discipline and deleveraging.

• Guidance is subject to input cost and forex volatility.

• Q4 expected to be seasonally strong, with higher sales and free cash flow.